With a gain of more than 531% over the last 12 months, shares of Viking Therapeutics (NASDAQ: VKTX) are a hot commodity, to say the least. And as of early November, there's one more big green flag ...

Ionis Pharmaceuticals announced the acceptance of a New Drug Application for donidalorsen for prophylactic ... Viking Therapeutics reported updated, early-stage study results on its oral obesity drug ...

Obesity caused by a lifestyle of moving less and eating more is a prime factor contributing to Type 2 diabetes. Is the answer new weight loss drugs?

Opens in a new tab or window SAN ANTONIO -- Patients with overweight or obesity lost an average one-fifth of their ... "You ...

The U.S. Food and Drug Administration has added a new warning to drugs including Ozempic and Wegovy ... Medical providers ...

The Impact of New Weight Loss Drugs on Dietetics By Carrie Dennett, MPH, RDN Today’s Dietitian Vol. 26 No. 9 P. 14 What’s changed for weight-inclusive and weight management dietitians?

Popular weight-loss drug Wegovy maker Novo Nordisk expects high demand and acceptance for its anti-obesity drug, when ...

Shares of AstraZeneca dropped more than 7% yesterday after the Chinese publication Yicai Global reported that dozens of ...

Danish pharmaceutical giant Novo Nordisk, maker of the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, posted Wednesday strong third-quarter earnings despite being held back by ...

New CDC population data from 2023 show that in 23 states more than one in three adults (35 percent) has obesity. Before 2013, no state had an adult obesity prevalence at or above 35 percent. Currently ...

Amid the rise of gut health and GLP-1 drugs in the UK, Potina is making high-fibre banana oat milks for improved children's ...